Kathryn R Koller1, Jesse S Metzger2, Stacey E Jolly3, Jason G Umans4, Scarlett E Hopkins5, Cristiane Kaufmann5, Amy S Wilson6, Sven O E Ebbesson7, Terry W Raymer6, Melissa A Austin8, Barbara V Howard4, Bert B Boyer5. 1. Alaska Native Tribal Health Consortium, Division of Community Health Services, Anchorage, AK, United States. Electronic address: kkoller@anthc.org. 2. University of Alaska Anchorage, Anchorage, AK, United States. 3. Cleveland Clinic Medicine Institute, Cleveland, OH, United States. 4. MedStar Health Research Institute, Hyattsville, MD, United States; Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, United States. 5. University of Alaska Fairbanks, Center for Alaska Native Health Research, Fairbanks, AK, United States. 6. Alaska Native Tribal Health Consortium, Division of Community Health Services, Anchorage, AK, United States. 7. Norton Sound Health Corporation, Nome, AK, United States. 8. University of Washington, Seattle, WA, United States.
Abstract
AIMS: Previously rare among Alaska Native (AN) people, type 2 diabetes (DM2) prevalence as indicated by registry data has increased by as much as 300% in some western Alaska regions. We sought to determine prevalence and incidence of DM2 and analyze associated cardiometabolic risk factors in western AN people. METHODS: DM2 and prediabetes prevalence and incidence were determined by the Western Alaska Tribal Collaborative for Health using consolidated data from cohort studies conducted during 2000-2010. Crude and age-adjusted incidence for DM2 and prediabetes were calculated using 2010 American Diabetes Association criteria. Effects of covariates on DM2 and prediabetes were determined using univariate and multivariate Cox proportional hazards analyses, adjusted for age and sex. RESULTS: Excluding baseline diabetes (n=124, 4.5%), 53 cases of new DM2 were identified among 2630 participants. Age- and sex-adjusted DM2 incidence was 4.3/1000 (95% CI 2.9, 5.0) person-years over an average 5.9-year follow up. After excluding baseline prediabetes, 387 new cases of prediabetes were identified among 1841 participants; adjusted prediabetes incidence was 44.5/1000 (95% CI 39.5, 49.5) person years. Independent predictors for DM2 included age, impaired fasting glucose, and metabolic syndrome; family history of diabetes and obesity were additional independent predictors for prediabetes. CONCLUSIONS: DM2 incidence in western AN people is substantially lower than that for U.S. whites; however, incidence of prediabetes is more than 10-fold higher than western AN DM2 incidence and more closely aligned with U.S. rates. Interventions aimed at achieving healthy lifestyles are needed to minimize risk factors and maximize protective factors for DM2 in this population.
AIMS: Previously rare among Alaska Native (AN) people, type 2 diabetes (DM2) prevalence as indicated by registry data has increased by as much as 300% in some western Alaska regions. We sought to determine prevalence and incidence of DM2 and analyze associated cardiometabolic risk factors in western AN people. METHODS:DM2 and prediabetes prevalence and incidence were determined by the Western Alaska Tribal Collaborative for Health using consolidated data from cohort studies conducted during 2000-2010. Crude and age-adjusted incidence for DM2 and prediabetes were calculated using 2010 American Diabetes Association criteria. Effects of covariates on DM2 and prediabetes were determined using univariate and multivariate Cox proportional hazards analyses, adjusted for age and sex. RESULTS: Excluding baseline diabetes (n=124, 4.5%), 53 cases of new DM2 were identified among 2630 participants. Age- and sex-adjusted DM2 incidence was 4.3/1000 (95% CI 2.9, 5.0) person-years over an average 5.9-year follow up. After excluding baseline prediabetes, 387 new cases of prediabetes were identified among 1841 participants; adjusted prediabetes incidence was 44.5/1000 (95% CI 39.5, 49.5) person years. Independent predictors for DM2 included age, impaired fasting glucose, and metabolic syndrome; family history of diabetes and obesity were additional independent predictors for prediabetes. CONCLUSIONS:DM2 incidence in western AN people is substantially lower than that for U.S. whites; however, incidence of prediabetes is more than 10-fold higher than western AN DM2 incidence and more closely aligned with U.S. rates. Interventions aimed at achieving healthy lifestyles are needed to minimize risk factors and maximize protective factors for DM2 in this population.
Authors: Meera L Narayanan; Cynthia D Schraer; Lisa R Bulkow; Kathryn R Koller; Elvin Asay; Ann Marie Mayer; Terry W Raymer Journal: Int J Circumpolar Health Date: 2010-05-25 Impact factor: 1.228
Authors: Barbara V Howard; Jesse S Metzger; Kathryn R Koller; Stacey E Jolly; Elvin D Asay; Hong Wang; Abbie W Wolfe; Scarlett E Hopkins; Cristiane Kaufmann; Terry W Raymer; Brian Trimble; Ellen M Provost; Sven O E Ebbesson; Melissa A Austin; William James Howard; Jason G Umans; Bert B Boyer Journal: Am J Public Health Date: 2014-04-22 Impact factor: 9.308
Authors: S O Ebbesson; C D Schraer; P M Risica; A I Adler; L Ebbesson; A M Mayer; E V Shubnikof; J Yeh; O T Go; D C Robbins Journal: Diabetes Care Date: 1998-04 Impact factor: 19.112
Authors: Sven O E Ebbesson; Lars O E Ebbesson; Michael Swenson; John M Kennish; David C Robbins Journal: Int J Circumpolar Health Date: 2005-09 Impact factor: 1.228
Authors: Hong Wang; Nawar M Shara; Darren Calhoun; Jason G Umans; Elisa T Lee; Barbara V Howard Journal: Diabetes Metab Res Rev Date: 2010-07 Impact factor: 4.876
Authors: Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal Journal: JAMA Date: 2006-04-05 Impact factor: 56.272
Authors: Kathryn R Koller; Abbie W Wolfe; Jesse S Metzger; Melissa A Austin; Scarlett E Hopkins; Cristiane Kaufmann; Stacey E Jolly; Sven O E Ebbesson; Jason G Umans; Barbara V Howard; Bert B Boyer Journal: Int J Circumpolar Health Date: 2013-05-02 Impact factor: 1.228
Authors: Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Christi A Patten; Vanessa Y Hiratsuka; Sarah H Nash; Gretchen Day; Diana G Redwood; Julie A Beans; Barbara V Howard; Jason G Umans; Kathryn R Koller Journal: Nicotine Tob Res Date: 2022-04-28 Impact factor: 5.825
Authors: Kathryn R Koller; Gretchen E Day; Vanessa Y Hiratsuka; Julie A Beans; Sarah H Nash; Diana G Redwood; Jianhui Zhu; Barbara V Howard; Jason G Umans Journal: Diabetes Res Clin Pract Date: 2020-07-31 Impact factor: 5.602
Authors: Bert B Boyer; Scarlett E Hopkins; Howard W Wiener; Jonathan Q Purnell; Diane M O'Brien; Cindy X Zhang; Joseph E Aslan; Theresa Aliwarga; Jeremy J Pomeroy; Kenneth E Thummel; Hemant K Tiwari Journal: J Nutr Date: 2022-03-03 Impact factor: 4.798
Authors: Jason F Deen; Alexandra K Adams; Amanda Fretts; Stacey Jolly; Ana Navas-Acien; Richard B Devereux; Dedra Buchwald; Barbara V Howard Journal: J Am Heart Assoc Date: 2017-10-24 Impact factor: 5.501
Authors: Natalie D Riediger; Kirsten Clark; Virginia Lukianchuk; Joanne Roulette; Sharon Bruce Journal: Int J Circumpolar Health Date: 2017 Impact factor: 1.228
Authors: Jacques Philip; Tove K Ryman; Scarlett E Hopkins; Diane M O'Brien; Andrea Bersamin; Jeremy Pomeroy; Kenneth E Thummel; Melissa A Austin; Bert B Boyer; Kirk Dombrowski Journal: PLoS One Date: 2017-11-01 Impact factor: 3.240
Authors: Diana G Redwood; Gretchen M Day; Julie A Beans; Vanessa Y Hiratsuka; Sarah H Nash; Barbara V Howard; Jason G Umans; Kathryn R Koller Journal: Curr Dev Nutr Date: 2019-10-09
Authors: Sarah H Nash; Gretchen Day; Vanessa Y Hiratsuka; Julie Beans; Diana Redwood; Peter Holck; Barbara V Howard; Jason Umans; Kathryn R Koller Journal: Nutr Metab Cardiovasc Dis Date: 2020-09-24 Impact factor: 4.222